GenSight Biologics S.A. (EPA: SIGHT)

GenSight Biologics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 19, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	32	26	155	255	304	81
Market Cap Growth	-5.37%	-83.46%	-39.23%	-16.09%	275.09%	-1.47%
Enterprise Value	48	46	147	220	304	75
Last Close Price	0.28	0.46	3.36	5.56	7.13	2.48
PS Ratio	9.36	8.66	31.90	33.13	40.91	16.53
PB Ratio	-1.32	-0.84	-10.16	15.97	25.90	7.71
P/TBV Ratio	-	-	-	16.08	26.20	7.83
EV/Sales Ratio	24.14	15.53	30.24	28.53	40.80	15.17
Debt / Equity Ratio	-0.91	-0.77	-1.17	1.09	1.63	1.03
Asset Turnover	0.12	0.17	0.12	0.15	0.19	0.14
Quick Ratio	0.49	0.18	0.96	2.18	2.41	2.10
Current Ratio	0.77	0.26	1.57	2.40	2.56	2.30
Return on Equity (ROE)	-	-	-7781.69%	-206.34%	-305.52%	-179.53%
Return on Assets (ROA)	-78.84%	-105.83%	-42.13%	-33.80%	-39.04%	-54.52%
Return on Capital (ROIC)	-	-	-96.45%	-54.62%	-59.68%	-77.83%
Earnings Yield	-108.70%	-102.16%	-17.80%	-11.21%	-11.18%	-38.04%
FCF Yield	-49.48%	-96.14%	-21.91%	-6.72%	-4.94%	-34.73%
Buyback Yield / Dilution	-44.26%	-4.29%	-2.61%	-28.54%	-23.76%	-16.00%
Total Shareholder Return	-44.26%	-4.29%	-2.61%	-28.54%	-23.76%	-16.00%

Source: S&P Capital IQ. Standard template. Financial Sources.